熱門資訊> 正文
下一篇Cure GAAP每股收益为-19.65美元
2026-03-06 15:47
- NextCure press release (NXTC): FY GAAP EPS of -$19.65.
- Cash, cash equivalents, and marketable securities as of December 31, 2025 were $41.8 million as compared to $68.6 million as of December 31, 2024.
More on NextCure
- Seeking Alpha’s Quant Rating on NextCure
- Historical earnings data for NextCure
- Financial information for NextCure
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。